Development of a Subcutaneous Fixed-Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose-Finding Study
Journal of Clinical Pharmacology - United States
doi 10.1002/jcph.1362
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 19, 2018
Authors
Publisher
Wiley